Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPRED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C5orf42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF664-FAM101A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMRT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HOMER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXQ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC37L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCMTD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC8A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on